Needham Reiterates Buy on DocGo, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Ryan MacDonald has reiterated a 'Buy' rating on DocGo (NASDAQ:DCGO) and maintained a price target of $14.
September 07, 2023 | 10:31 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
DocGo's stock rating has been reiterated as 'Buy' by Needham analyst Ryan MacDonald, with a maintained price target of $14.
The reiteration of a 'Buy' rating by a reputable analyst like Ryan MacDonald from Needham is a positive signal for DocGo. The maintained price target of $14 also indicates confidence in the company's performance. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100